VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+10.35%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$113M
AUM Growth
+$113M
(-1.9%)
Cap. Flow
-$8.35M
Cap. Flow
% of AUM
-7.38%
Top 10 Holdings %
Top 10 Hldgs %
14.17%
Holding
280
New
34
Increased
62
Reduced
100
Closed
19
Top Buys
| 1 |
Fidelity MSCI Financials Index ETF
FNCL
|
$1.41M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.15M |
| 3 |
Verastem
VSTM
|
$985K |
| 4 |
Arrowhead Research
ARWR
|
$933K |
| 5 |
Cartesian Therapeutics
RNAC
|
$884K |
Top Sells
Sector Composition
| 1 | Healthcare | 77.9% |
| 2 | Financials | 0.8% |
| 3 | Technology | 0.58% |
| 4 | Consumer Discretionary | 0.4% |
| 5 | Energy | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $4.46M | 3.95% | 36,665 +9,465 | +35% | +$1.15M |
|
2
Vanguard Utilities ETF
VPU
$7.27B
| $2.38M | 2.11% | 20,545 -2,300 | -10% | -$267K |
|
|
3
Fidelity MSCI Financials Index ETF
FNCL
$2.37B
| $1.41M | 1.24% | +35,927 | New | +$1.41M |
|
4
Vanguard Energy ETF
VDE
$7.42B
| $1.39M | 1.23% | 13,206 +1,808 | +16% | +$190K |
|
5
iShares MSCI India ETF
INDA
$9.17B
| $1.24M | 1.09% | 37,169 +767 | +2% | +$25.5K |
|
|
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.09M | 0.96% | 22,469 +1,648 | +8% | +$79.9K |
|
7
Vanguard Real Estate ETF
VNQ
$34.6B
| $1.06M | 0.93% | 12,955 +19 | +0.1% | +$1.55K |
|
8
Regenxbio
RGNX
$451M
| $1.04M | 0.92% | 14,492 -12,068 | -45% | -$866K |
|
|
9
Verastem
VSTM
$569M
| $985K | 0.87% | +143,188 | New | +$985K |
|
10
Sarepta Therapeutics
SRPT
$1.78B
| $977K | 0.86% | 7,391 -9,018 | -55% | -$1.19M |
|
|
11
Arrowhead Research
ARWR
$3.05B
| $933K | 0.82% | +68,587 | New | +$933K |
|
|
TVRD
12
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $927K | 0.82% | 48,423 -10,953 | -18% | -$210K |
|
|
13
Cartesian Therapeutics
RNAC
$261M
| $884K | 0.78% | +66,701 | New | +$884K |
|
|
ALBO
14
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $876K | 0.77% | +24,688 | New | +$876K |
|
15
uniQure
QURE
$896M
| $872K | 0.77% | 23,063 -19,441 | -46% | -$735K |
|
16
FibroGen
FGEN
$47.8M
| $860K | 0.76% | 13,732 -4,528 | -25% | -$284K |
|
|
ATNX
17
DELISTED
Athenex, Inc. Common Stock
ATNX
| $846K | 0.75% | 45,314 +706 | +2% | +$13.2K |
|
|
CCXI
18
DELISTED
ChemoCentryx, Inc.
CCXI
| $841K | 0.74% | +63,829 | New | +$841K |
|
|
CBAY
19
DELISTED
Cymabay Therapeutics
CBAY
| $831K | 0.73% | 61,951 -31,366 | -34% | -$421K |
|
|
MYOK
20
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $823K | 0.73% | 16,580 -3,022 | -15% | -$150K |
|
21
BioCryst Pharmaceuticals
BCRX
$1.74B
| $820K | 0.73% | 143,132 -11,015 | -7% | -$63.1K |
|
22
Abeona Therapeutics
ABEO
$350M
| $817K | 0.72% | 51,041 +3,892 | +8% | +$62.3K |
|
23
Clearside Biomedical
CLSD
$28.9M
| $814K | 0.72% | +76,173 | New | +$814K |
|
|
MRTX
24
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $810K | 0.72% | 16,429 -26,707 | -62% | -$1.32M |
|
25
Vertex Pharmaceuticals
VRTX
$100B
| $801K | 0.71% | 4,711 -1,623 | -26% | -$276K |
|